European guidelines on the clinical management of HIV-1 tropism testing von Vandekerckhove, LPR, MD, Wensing, AMJ, MD, Kaiser, R, MD, Brun-Vézinet, F, Prof, Clotet, B, MD, De Luca, A, MD, Dressler, S, MD, Garcia, F, PhD, Geretti, AM, MD, Klimkait, T, Prof, Korn, K, MD, Masquelier, B, PharmD, Perno, CF, Prof, Schapiro, JM, MD, Soriano, V, Prof, Sönnerborg, A, Prof, Vandamme, A-M, Prof, Verhofstede, C, PhD, Walter, H, MD, Zazzi, M, MSc, Boucher, CAB, Prof

Volltext

Drug-resistance genotyping in HIV-1 therapy : the VIRADAPT randomised controlled trial von DURANT, J, CLEVENBERGH, P, HALFON, P, DELGIUDICE, P, PORSIN, S, SIMONET, P, MONTAGNE, N, BOUCHER, C. A. B, SCHAPIRO, J. M, DELLAMONICA, P

Volltext

Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy : pharmacological data from the Viradapt Study von DURANT, J, CLEVENBERGH, P, GARRAFFO, R, HALFON, P, ICARD, S, DEL GIUDICE, P, MONTAGNE, N, SCHAPIRO, J. M, DELLAMONICA, P

Volltext

Nucleoside reverse transcriptase inhibitors in combination therapy for HIV patients: systematic review and meta-analysis von Chowers, M, Gottesman, B.-S, Leibovici, L, Schapiro, J. M, Paul, M

Volltext

Drug-Resistant HIV Infection among Drug-Naive Patients in Israel von Grossman, Z., Lorber, M., Maayan, S., Yacov, N. Bar, Levy, I., Averbuch, D., Istomin, V., Chowers, M., Sthoeger, Z., Ram, D., Rudich, H., Mileguir, F., Pavel, R., Almaliach, R., Schlaeffer, F., Oz, Z. Kra, Mendelson, E., Schapiro, J. M., Riesenberg, K.

Volltext

Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up von Clevenbergh, P, Durant, J, Halfon, P, del Giudice, P, Mondain, V, Montagne, N, Schapiro, J M, Boucher, C A, Dellamonica, P

Volltext

Methods for Investigation of the Relationship between Drug-Susceptibility Phenotype and Human Immunodeficiency Virus Type 1 Genotype with Applications to AIDS Clinical Trials Group... von Sevin, Anne D., DeGruttola, Victor, Nijhuis, Monique, Schapiro, Jonathan M., Foulkes, Andrea S., Para, Michael F., Boucher, Charles A. B.

Volltext

Human Immunodeficiency Virus Type 1 Protease Genotypes and In Vitro Protease Inhibitor Susceptibilities of Isolates from Individuals Who Were Switched to Other Protease Inhibitors... von Winters, M A, Schapiro, J M, Lawrence, J, Merigan, T C

Volltext

HIV-1 Protease and Reverse-Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance von Rhee, Soo-Yon, Fessel, W. Jeffrey, Zolopa, Andrew R., Hurley, Leo, Liu, Tommy, Taylor, Jonathan, Nguyen, Dong Phuong, Slome, Sally, Klein, Daniel, Horberg, Michael, Flamm, Jason, Follansbee, Stephen, Schapiro, Jonathan M., Shafer, Robert W.

Volltext

Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience von GRAY, C. M, SCHAPIRO, J. M, WINTERS, M. A, MERIGAN, T. C

Volltext

Inhibition of Bacterial DNA Replication by Zinc Mobilization during Nitrosative Stress von Schapiro, Jeffrey M., Libby, Stephen J., Fang, Ferric C.

Volltext

Economic evaluation of drug resistance genotyping for the adaptation of treatment in HIV-infected patients in the VIRADAPT study von CHAIX, C, GRENIER-SENNELIER, C, CLEVENBERGH, P, DURANT, J, SCHAPIRO, J. M, DELLAMONICA, P, DURAND-ZALESKI, I

Volltext

Therapeutic drug monitoring: An aid to optimising response to antiretroviral drugs? von AARNOUTSE, Rob E, SCHAPIRO, Jonathan M, BOUCHER, Charles A. B, HEKSTER, Yechiel A, BURGER, David M

Volltext

HIV-1 pol mutation frequency by subtype and treatment experience : extension of the HIVseq program to seven non-B subtypes von RHEE, Soo-Yon, KANTOR, Rami, KATZENSTEIN, David A, CAMACHO, Ricardo, MORRIS, Lynn, SIRIVICHAYAKUL, Sunee, JORGENSEN, Louise, BRIGIDO, Luis F, SCHAPIRO, Jonathan M, SHAFER, Robert W

Volltext

Frequency of Class I HLA-Restricted Anti-HIV CD8+ T Cells in Individuals Receiving Highly Active Antiretroviral Therapy (HAART) von Gray, Clive M, Lawrence, Jody, Schapiro, Jonathan M, Altman, John D, Winters, Mark A, Crompton, Meg, Loi, Muoi, Kundu, Smriti K, Davis, Mark M, Merigan, Thomas C

Volltext

Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel von Maor, Y., Morali, G., Bashari, D., Pénaranda, G., Schapiro, J. M., Martinowitz, U., Halfon, P.

Volltext

Hepatitis C at the Israeli National Hemophilia Center von MAOR, Y., BASHARI, D., KENET, G., LALEZARI, S., LUBETSKY, A., LUBOSHITZ, J., SCHAPIRO, J. M., AVIDAN, B., BAR-MEIR, S., MARTINOWITZ, U.

Volltext

Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations von SCHAPIRO, J. M, WINTERS, M. A, LAWRENCE, J, MERIGAN, T. C

Volltext

Localization of a gene causing cystinuria to chromosome 2p von Arber, Nadir, Aksentijevich, Ivona, Liberman, Uri, Kastner, Daniel L, Weissenbach, Jean, Prosen, Leandrea, Katz, Giora, Harel, Daniela, Pras, Mordechai, Schapiro, Jonathan M, Pras, Elon, Gruberg, Luis

Volltext

Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel von Hirsch, Martin S., Günthard, Huldrych F., Schapiro, Jonathan M., Vézinet, Françoise Brun, Clotet, Bonaventura, Hammer, Scott M., Johnson, Victoria A., Kuritzkes, Daniel R., Mellors, John W., Pillay, Deenan, Yeni, Patrick G., Jacobsen, Donna M., Richman, Douglas D.

Volltext